Temasek Holdings Portfolio holdings
AUM
$37.3B
Turnover
40.09%
1-Year Est. Return
12.6%
This Fund
S&P 500
This Quarter
Est. Return
-2.09%
1 Year Est. Return
+12.6%
3 Year Est. Return
+93.72%
5 Year Est. Return
+64.47%
10 Year Est. Return
+501.94%
AUM
$12.8B
AUM Growth
+$109M
(+0.86%)
Cap. Flow
+$529M
Cap. Flow
% of AUM
4.13%
Top 10 Holdings %
Top 10 Hldgs %
89.64%
Holding
31
New
3
Increased
2
Reduced
1
Closed
2
Avg Time Held
1.5
years
Top 10 Avg Time Held
1.6
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$511M |
| 2 |
BEAV
B/E Aerospace Inc
BEAV
|
+$102M |
| 3 |
Intellia Therapeutics
NTLA
|
+$21M |
| 4 |
ICICI Bank
IBN
|
+$18.1M |
| 5 |
UNVR
Univar Solutions Inc.
UNVR
|
+$82.6K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$42.4M |
| 2 |
IQVIA
IQV
|
+$42.1M |
| 3 |
MON
Monsanto Co
MON
|
+$31.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 35.35% |
| 2 | Industrials | 26.93% |
| 3 | Healthcare | 17.96% |
| 4 | Communication Services | 5.57% |
| 5 | Materials | 5.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Alibaba
BABA
$277B
| $4.3B | 33.6% |
54,076,397
+6,526,596
| +14% | +$511M |
2014 Q3
7 quarters
|
|
|
LVLT
2
DELISTED
Level 3 Communications Inc
LVLT
| $3.35B | 26.16% |
65,031,667
| – | – |
2013 Q2
12 quarters
|
|
3
Gilead Sciences
GILD
$190B
| $1.15B | 9.01% |
13,830,516
| – | – |
2013 Q4
10 quarters
|
|
4
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $690M | 5.39% |
21,173,310
| – | – |
2014 Q3
7 quarters
|
|
5
Thermo Fisher Scientific
TMO
$249B
| $428M | 3.35% |
2,899,315
| – | – |
2014 Q1
9 quarters
|
|
|
UNVR
6
DELISTED
Univar Solutions Inc.
UNVR
| $428M | 3.35% |
22,641,230
+4,546
| +0% | +$82.6K |
2015 Q2
4 quarters
|
|
7
DELISTED
EMC CORPORATION
EMC
| $384M | 3% |
14,141,103
| – | – |
2015 Q2
4 quarters
|
|
8
BioMarin Pharmaceuticals
BMRN
$10.7B
| $270M | 2.11% |
3,472,712
| – | – |
2014 Q1
9 quarters
|
|
|
TRQ
9
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $247M | 1.93% |
7,321,388
| – | – |
2013 Q2
12 quarters
|
|
10
Virtu Financial
VIRT
$4.9B
| $222M | 1.73% |
12,317,682
| – | – |
2015 Q2
4 quarters
|
|
11
PayPal
PYPL
$48B
| $197M | 1.54% |
5,387,963
| – | – |
2015 Q3
3 quarters
|
|
12
Synchrony
SYF
$23.3B
| $166M | 1.3% |
6,561,333
| – | – |
2015 Q4
2 quarters
|
|
|
PTLA
13
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $155M | 1.21% |
6,583,568
| – | – |
2013 Q2
12 quarters
|
|
14
JD.com
JD
$36B
| $155M | 1.21% |
7,306,572
| – | – |
2015 Q4
2 quarters
|
|
|
ALXN
15
DELISTED
Alexion Pharmaceuticals
ALXN
| $143M | 1.12% |
1,226,630
| – | – |
2015 Q2
4 quarters
|
|
16
VNET Group
VNET
$1.28B
| $110M | 0.86% |
10,778,004
| – | – |
2013 Q4
10 quarters
|
|
|
BEAV
17
DELISTED
B/E Aerospace Inc
BEAV
| $98.2M | 0.77% |
+2,126,523
| New | +$102M |
2016 Q2
0 quarters
|
|
18
Tuniu
TOUR
$53.8M
| $69.1M | 0.54% |
819,444
| – | – |
2015 Q4
2 quarters
|
|
19
Regeneron Pharmaceuticals
REGN
$80.1B
| $44.1M | 0.34% |
126,351
| – | – |
2015 Q4
2 quarters
|
|
20
Illumina
ILMN
$41B
| $38.9M | 0.3% |
285,024
| – | – |
2015 Q4
2 quarters
|
|
|
JUNO
21
DELISTED
Juno Therapeutics, Inc.
JUNO
| $35.2M | 0.28% |
915,750
| – | – |
2014 Q4
6 quarters
|
|
|
AMRS
22
DELISTED
Amyris Inc.
AMRS
| $31.4M | 0.25% |
4,639,481
| – | – |
2013 Q2
12 quarters
|
|
|
EMWP
23
DELISTED
Eros Media World PLC
EMWP
| $22.4M | 0.17% |
68,800
| – | – |
2014 Q3
7 quarters
|
|
|
24
ICICI Bank
IBN
$101B
| $18.3M | 0.14% |
+2,808,988
| New | +$18.1M |
2016 Q2
0 quarters
|
|
|
25
Intellia Therapeutics
NTLA
$1.6B
| $16.9M | 0.13% |
+790,527
| New | +$21M |
2016 Q2
0 quarters
|
|
Similar funds
ECSS
PIF
TWC
Temasek Holdings's Q2 2016 Portfolio in Review
As of Q2 2016, Temasek Holdings held 31 positions worth $12.8B, up 0.86% from $12.7B the previous quarter. Its ten largest holdings account for 90% of the portfolio.
Temasek Holdings deployed $529M of net new capital in Q2 2016, opening 3 new positions and adding to 2 existing holdings. Its largest new stake was B/E Aerospace Inc: 2,126,523 shares worth $98.2M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 35% of assets, up from 32% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was IQVIA, an estimated $42.1M trimmed.
- Temasek Holdings's largest Q2 2016 buy was B/E Aerospace Inc: 2,126,523 shares worth $98.2M.
- Temasek Holdings added most to Alibaba in Q2 2016, an estimated $511M increase.
- Temasek Holdings's biggest Q2 2016 reduction was IQVIA, cutting an estimated $42.1M.
- Temasek Holdings fully exited Fidelity National Information Services in Q2 2016, selling an estimated $42.4M.
- Temasek Holdings's ten largest holdings make up 90% of its $12.8B portfolio in Q2 2016.
- Temasek Holdings opened 3 new positions and closed 2 in Q2 2016.
- Temasek Holdings's portfolio value rose 0.86% quarter-over-quarter to $12.8B.
Based on Temasek Holdings's 13F filing for Q2 2016, filed 15 Aug 2016.